Search
Sep 26, 2024
Houston Oncology Summit: Oppenheimer analysts Jeff Jones and Jay Olson talk radiopharmaceuticals and antibody-drug conjugates
Jeff Jones notes how radioisotopes are being added to more than just antibodies, and calls out upcoming data from Perspective...
Sep 21, 2023
Houston Oncology Summit: Oppenheimer analyst Jeff Jones on the growth of radiopharmaceuticals
Jeff Jones describes the science behind radiopharmaceuticals and how both new targets and better isotopes are making them more effective.